cannabidiol – CFN Media

Cardiol Therapeutics Advancing Orphan Drug Trial to Phase 2/3

Clinical trials are crucial for smaller pharma companies. While the ultimate aim…

Robin Lefferts
October 28, 2024

Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis

MAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of interleukin-1…

Ryan Allway
October 22, 2024

The Impact of Positive Phase 2 Trial Results on a Smaller Company

A few weeks back, we covered the effect an Orphan Drug Designation…

Robin Lefferts
March 12, 2024

The Impact of Orphan Drug Development on a Smaller Company

Orphan drugs treat conditions with less than 200,000 patients annually in the…

Robin Lefferts
February 6, 2024

Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Toronto, Ontario–(Newsfile Corp. – November 16, 2023) – Cardiol Therapeutics Inc. (NASDAQ: CRDL)…

Ryan Allway
November 16, 2023

Virpax Pharmaceuticals Engages Dr. Kenneth W. Sommerville and Dr. Lawrence Fried to Assist in Development of NobrXiol™ (formerly VRP324)

BERWYN, Pa., January 04, 2023–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:…

Ryan Allway
January 4, 2023

Virpax Pharmaceuticals Reports on FDA Pre-IND Response for NobrXiol™ (formerly VRP324)

–VRPX Intranasal Cannabidiol Product Candidate for Management of Epilepsy in Children and…

Ryan Allway
December 14, 2022

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Cardiol’s Favorable Phase 2 Results Set the Table for Advanced Clinical Trials

Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) recently presented excellent…

Robin Lefferts
November 20, 2024

Aduro Clean Technologies Engages Global Leader Zeton for Design and Fabrication of Hydrochemolytic™ Pilot Plant

Milestone Project to Demonstrate Aduro’s Modular, Scalable Solution for Converting…

Ryan Allway
November 19, 2024

IKE Tech LLC and Ispire Technology Inc. Announce Positive Pre-PMTA Submission Meeting with the FDA

Seeks Authorization for Pioneering Point-of-Use Identity and Age Verification…

Ryan Allway
November 18, 2024

Healthcare Stocks

Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

Marked and rapid reductions in both pericarditis pain and inflammation maintained…

Ryan Allway
November 18, 2024